Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis

QR Code

Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis

Abstract The high prevalence of diabetes mellitus (DM) among multidrug resistant tuberculosis (MDR-TB) patients is a serious cause for concern. We conducted a meta-analysis to determine whether DM is an independent risk factor for MDR-TB. Electronic literature searches of the PubMed, Web of Science...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Qianqian Liu, Wenzhang Li, Miao Xue, Yunfeng Chen, Xinmiao Du, Chengdi Wang, Lina Han, Yin Tang, Yulin Feng, Chuanmin Tao, Jian-Qing He
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2017
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/d5bae6ecf94b4573b0380787e7763daa
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
par: Diana Machado, et autres
Publié: (2012)

GENETIC DIVERSITY OF MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES IN PAKISTAN
par: Z. Bakuła, et autres
Publié: (2018)

High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
par: Larissa Otero, et autres
Publié: (2011)

Genetic Diversity and Transmission of Multidrug-Resistant Mycobacterium tuberculosis strains in Lusaka, Zambia
par: Joseph Yamweka Chizimu, et autres
Publié: (2022)

Genomic Analysis of Multidrug-Resistant Mycobacterium tuberculosis Strains From Patients in Kazakhstan
par: Asset Daniyarov, et autres
Publié: (2021)

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.
par: Ying-Cheng Qi, et autres
Publié: (2012)

PRIMARY MULTIDRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIUM ACCORDING TO DATA OF KRASNOYARSK REGIONAL TUBERCULOSIS DISPENSARY № 1 IN-PATIENT DEPARTMENT
par: N. M. Koretskaya, et autres
Publié: (2012)

Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait
par: Noura M. Al-Mutairi, et autres
Publié: (2021)

The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis.
par: Dick van Soolingen, et autres
Publié: (2010)

Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
par: Stellah G Mpagama, et autres
Publié: (2013)

Increased risk of hepatotoxicity and hyperuricemia in elderly Taiwanese multidrug-resistant tuberculosis patients taking pyrazinamide
par: D. Truong, et autres
Publié: (2016)

Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in China
par: Hongbing Jia, et autres
Publié: (2021)

Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam.
par: Nguyen Bao Ngoc, et autres
Publié: (2021)

An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia.
par: Yanina Balabanova, et autres
Publié: (2009)

Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection.
par: Nuntita Singpanomchai, et autres
Publié: (2021)

Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting
par: Kevin Montes, et autres
Publié: (2021)

EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
par: I. A. Morozov, et autres
Publié: (2016)

Detection of serum isoniazid concentration in patients with multidrug-resistant tuberculosis using high-performance liquid chromatography
par: M. K. Vinokurova, et autres
Publié: (2018)

Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.
par: Hind Satti, et autres
Publié: (2012)

Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
par: Hind Satti, et autres
Publié: (2012)

Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.
par: Petros Isaakidis, et autres
Publié: (2013)

Molecular epidemiology of multidrug resistant tuberculosis in Mongolia and Eastern Siberia: two independent dissemination processes for dominant strains
par: S. N. Zhdanova, et autres
Publié: (2021)

Epidemiological analysis of factors influencing the course of multidrug-resistant tuberculosis in HIV-infected patients with concomitant viral hepatitis
par: A. V. Kukurika, et autres
Publié: (2021)

Key factors influencing multidrug-resistant tuberculosis in patients under anti-tuberculosis treatment in two centres in Burundi: a mixed effect modelling study
par: Arnaud Iradukunda, et autres
Publié: (2021)

From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
par: Karolien Stoffels, et autres
Publié: (2013)

Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing
par: Xinchang Chen, et autres
Publié: (2020)

LOOKING INSIDE THE FOREST: FROM CLASSICAL GENOTYPING OF MYCOBACTERIUM TUBERCULOSIS TO WHOLE GENOME SEQUENCING IN HIGH MULTIDRUG RESISTANCE SETTINGS
par: J. Perdigão
Publié: (2018)

GENOTYPING OF MULTIDRUG AND PREEXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES FROM A HIGH INCIDENCE TB AREA IN MOROCCO
par: I. Chaoui, et autres
Publié: (2018)

Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City
par: Elne Vieke Rambi, et autres
Publié: (2021)

The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
par: Colleen F Hanrahan, et autres
Publié: (2012)

Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
par: Olanrewaju Oladimeji, et autres
Publié: (2014)

High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis
par: Farah Naz, et autres
Publié: (2021)

Multidrug-resistant breast cancer: current perspectives
par: Martin HL, et autres
Publié: (2014)

Nanodrugs: optimism for emerging trend of multidrug resistance
par: Khan AU
Publié: (2012)

Transcriptional response to the host cell environment of a multidrug-resistant Mycobacterium tuberculosis clonal outbreak Beijing strain reveals its pathogenic features
par: Pakorn Aiewsakun, et autres
Publié: (2021)

Correlation of <i>gyr</i> Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in Bangladesh
par: Mohammad Khaja Mafij Uddin, et autres
Publié: (2021)

A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.
par: Pren Naidoo, et autres
Publié: (2014)

Photocatalytic Protein Damage by Silver Nanoparticles Circumvents Bacterial Stress Response and Multidrug Resistance
par: Tianyuan Shi, et autres
Publié: (2019)

The structural basis of promiscuity in small multidrug resistance transporters
par: Ali A. Kermani, et autres
Publié: (2020)

Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis
par: Xia Qiu, et autres
Publié: (2019)